Mitochondrial complex I, the largest enzyme complex of the mitochondrial oxidative phosphorylation machinery, has been proposed to contribute to a variety of age-related pathological alterations as well as longevity. The enzyme complex-consisting proteins are encoded by both nuclear (nDNA) and mitochondrial DNA (mtDNA). While some association studies of mtDNA-encoded complex I genes and lifespan in humans have been reported, experimental evidence and the functional consequence of such variants is limited to studies using invertebrate models. Here, we present experimental evidence that a homoplasmic mutation in the mitochondrially encoded complex I gene mt-Nd2 modulates lifespan by altering cellular tryptophan levels and, consequently, ageing-related pathways in mice. A conplastic mouse strain carrying a mutation at m.4738C>A in mt-Nd2 lived significantly shorter than the controls did. The same mutation led to a higher susceptibility to glucose intolerance induced by high-fat diet feeding. These phenotypes were not observed in mice carrying a mutation in another mtDNA-encoded complex I gene, mt-Nd5, suggesting the functional relevance of particular mutations in complex I to ageing and age-related diseases.
Introduction
Mitochondrial DNA encode genes for 2 ribosomal RNAs and the 22 transfer RNAs, as well as the 13 proteins of mitochondrial respiratory process, i.e., oxidative phosphorylation (OXPHOS) complexes 1, 2 . Of the five enzyme complexes of the mitochondrial respiratory process, OXPHOS complex I (NADH:ubiquinone oxidoreductase) is the largest enzyme, and is crucial for cellular metabolism by oxidising NADH and regenerating the NAD+ pool in the mitochondrial matrix 3 . A deficiency in complex I, caused by either the nuclear-encoded genome or mitochondrial genome (mtDNA) is reportedly associated with mitochondrial disorders both in children and adults, including Leigh syndrome, cardiomyopathy and encephalomyopathies 4, 5 .
In addition, the link between mutations in complex I and ageing has been shown in a number of studies using different model systems. Mutations in genes encoding subunits of complex I reportedly increase ROS levels and extend lifespan in worms and flies by independent mechanisms 6, 7 . Nuo-6 (qm200) worms, carrying a mutation in a conserved subunit of complex I, exhibit an extended lifespan by reducing oxygen consumption and decreasing complex I activities 6 . Flies with a knocked down expression of NDUFS1, a component of complex I, exhibited a longer lifespan via an increased mitochondrial unfolding protein response and the repression of insulin signalling 7 . Other studies showed that the stability of complex I is a critical factor for the extension of lifespan of mice 8 and worms 9 . In these two studies, opposite theories are suggested. The former indicates that the instability of complex I results in reduced ROS production, which extends the lifespan in mice 8 , while the latter shows that the destabilisation of the complex leads to a shortened lifespan in worms 9 . In addition, a recent study demonstrated that increased ROS production, specifically from complex I reverse electron transport, extends lifespan in flies 10 .
Apart from studies of nuclear genome-encoded complex I genes, mtDNA-encoded complex I genes are also reportedly involved in ageing, and this is supported by several studies exhibiting an association between mitochondrial DNA polymorphisms and lifespan in different 5 ethnic populations. These include the A variation at m.5178 in the ND2 gene (MT-ND2) accumulating in Japanese centenarians 11 20 . The former carries a homoplasmic mutation in mtDNA-encoded NADH dehydrogenase subunit 2 gene (mt-Nd2), and the latter has a homoplasmic mutation in the mtDNA-encoded NADH dehydrogenase subunit 5 gene (mtNd5). We specifically selected these conplastic strains to compare because they differ only in complex I genes (Supplementary Table 1) .
Results
A mutation in the mt-Nd2 gene results in a shorter lifespan in mice.
First, to evaluate the impact of mutations in complex I genes on lifespan in mice, we performed a longevity study using a large cohort of the two conplastic mouse strains carrying a mutation in mt-Nd2 (B6-mt ALR ) and mt-Nd5 and (B6-mt BPL ). The female B6-mt ALR mice lived approximately 60 days shorter than the B6-mt BPL mice did (p=0.0400, log-rank test; Fig. 1a and Supplementary Table 2) , while this significant difference was not observed in males or a sex-mixed analysis (p=0.4923, and p=0.1532, respectively; Fig. 1b, c) . In both strains, the incidence of spontaneous age-related diseases (i.e., tumours, ulcerative dermatitis and arthritis, Supplementary Fig. S1a ) and the ageing score ( Supplementary Fig. 1b ) were comparable. The days of vaginal patency and plasma IGF-1 levels in differently aged females showed no difference between the strains ( Supplementary Fig. 1c, d ).
The mt-Nd2 mutant mice exhibited mitochondrial functional differences under stress conditions. Fig. 2a) . A Western blot analysis of the heart proteins prepared from the young (3 to 4 months of age) and aged (18 to 22 months of age) mice revealed unaltered levels of the OXPHOS complex subunit proteins between the strains in both age groups (Fig. 2b) . The protein levels of 3 other subunits of mitochondrial complex I protein levels were also evaluated, and no differences was observed between the strains regardless their age group (Fig. 2c) . was measured using the same batch of primary lymphocytes used for the superoxide assay.
Next
The MMP was increased by the activation, while no difference in the levels of MMP was observed between the strains (Fig. 2f, left) . When the fold change of the MMP levels upon the activation was compared, the B6-mt ALR primary lymphocytes were less abundant than were the B6-mt BPL lymphocytes (descriptive p=0.0445, t test; Fig. 2f , right).
Higher levels of tryptophan were observed in the cells carrying the mt-Nd2 mutation. (Fig. 3a, Supplementary Fig.   2a ). To also obtain insights into the biosynthetic pathways leading to NAD+, the levels of tryptophan, an essential amino acid, which is degraded into NAD +21 , was determined by NMR in the skin fibroblast conplastic cell lines carrying the mt-Nd5 mutation or the mt-Nd2 mutation (Fig. 3b) . The levels of tryptophan in the cells carrying the mt-Nd2 mutation were identified to be higher than those in mt-Nd5 mutant cells (descriptive p=0.0295, t test; protein genes (Data S1). G0s2, a G0/G1 switch gene 2, shows an inhibitory capacity for the lipolytic enzyme adipose triglyceride lipase (ATGL) 22 , and the deletion of G0s2 ameliorates high-fat diet induced body weight gain and insulin resistance 23 . Leap2 (liver-expressed antimicrobial peptide 2) was recently revealed as an endogenous antagonist of the ghrelin receptor, controlling the blood glucose levels depending upon the nutrient status 24 , and Usmg5 (upregulated during skeletal muscle growth 5) is also increased in B6-mt ALR mice.
The gene encodes the protein USMG5, which is also called DAPIT (diabetes-associated protein in insulin-sensitive tissues). This protein was initially discovered in insulin-sensitive tissues of the streptozotocin-induced diabetic rats 25 , and its expression is reportedly higher in cells with a highly aerobic metabolism 26 . These findings indicate that the mutation in mt-Nd2 has an influence on lipid and glucose metabolism, as well as ATP production in the respiratory chain. Chchd1 (coiled-coil-helix-coiled-coil-helix domain-containing 1) is one of the recently identified mitochondrial ribosomal proteins, MRPS37 27 , suggesting that the mtNd2 variant affects mitochondrially encoded protein expression as well.
Pathways up-regulated in the short-lived B6-mt ALR mice included the OXPHOS, MYC target, fatty acid metabolism, E2F target, and mTORC1 signalling pathways (Fig. 4b) . The oncogene MYC reportedly targets genes involved in mitochondrial biogenesis, i.e., protein import, complex assembly, mitochondrial transcription/translation 28 . Recent studies showed that E2F regulates genes involved in mitochondrial functions via directly binding to their promoter regions (e.g., COX8 and CYB5-M), and through interactions with key regulatory factors of mitochondrial biogenesis, such as NRF1/2 and PGC-1 beta 29 . These pathway analysis data are in line with the phenotypes observed in the B6-mt ALR mice, i.e., shorter lifespan ( Fig. 1) and altered mitochondrial functions (Fig. 2 ). An additional pathway analysis using a different database also pointed in the same direction, i.e., the up-regulation of mitochondrial bioenergetics in B6-mt ALR mice ( Supplementary Fig. 3a, b) Earlier onset of glucose intolerance is induced by high-fat diet feeding in B6-mt ALR mice.
Lastly, to investigate whether the lifespan-linked mt-Nd2 mutation also contributes to other age-related phenotypes, we induced a diet-induced diabetes model in the female B6-mt ALR and B6-mt BPL mice. The high-fat diet (HFD) or control diet (CD) were started when mice were 4 weeks old. The HFD-fed mice acquired more body mass than did those fed the CD, while there was no strain difference in the HFD-nor CD-fed mice (Fig. 5a) . After 8 weeks of HFD feeding, an intraperitoneal glucose tolerance test (IPGTT) was performed, and the levels of glucose intolerance in the B6-mt ALR mice were higher than those in the B6-mt BPL mice, with a different time course in both strains (main effect of the strains: descriptive p=0.0238, interaction between strains and time: descriptive p<0.0001, two-way non-parametric analysis of variance; Fig. 5b ).
The levels of glucose and insulin in the morning-fasted serum samples were comparable between the two strains in the HFD-fed (Fig. 5c) , CD-fed groups (Supplementary Fig. 4c) , and in random-fed groups (Supplementary Fig. 4d ). The fructosamine levels were also unaltered between the random-fed B6-mt BPL and B6-mt ALR mice (Supplementary Fig 4d) ,
confirming that the basal glucose levels are similar between the strains. The lipid parameter assays revealed that the levels of total cholesterol in the HFD-fed mice mildly increased ( Fig.   5d ) compared with those in the CD-fed mice (Supplementary Fig. 4e ) and random-fed mice (Supplementary Fig. 4f) . Interestingly, the levels of total cholesterol and high-density cholesterol (HDL) were lower in the HFD-fed B6-mt ALR mice than those in the HFD-fed B6-mt BPL mice (descriptive p=0.0057 and 0.0038, respectively, t test; Fig. 5d ), while the levels of low-density cholesterol (LDL) were unaltered, resulting in a lower ratio of HDL to LDL in the B6-mt ALR mice compared to that in the B6-mt BPL mice (descriptive p=0.0054, t test; Fig. 5d ).
Changes in total cholesterol and the ratio of HDL to LDL were not detected in the CD-fed groups and random-fed groups ( Supplementary Fig. 4e, f) . Despite the unchanged triglyceride levels between the HFD-fed B6-mt ALR and HFD-fed B6-mt BPL mice, we observed that HFD-fed B6-mt ALR mice exhibited lower levels of free fatty acid than did the HFD-B6-mt BPL mice (descriptive p=0.0115, t test; Fig. 5c ), but this did not occur in the CD-fed mice (Supplementary Fig. 4e ), suggesting impaired beta oxidation in the B6-mt ALR mice under metabolic stress.
Cellular flux analysis was assessed in the primary hepatocytes isolated from the mice fed with HFD over 8 weeks, indicating the lower levels of basal respiration (descriptive p=0.0389, t test; Figure 5e ) and OXPHOS-linked ATP levels (descriptive p=0.0446, t test; Fig. 5f ) in the cells prepared from the B6-mt ALR mice than those in the cells from the B6-mt BPL mice.
We also observed a mildly delayed glucose clearance in the CD-fed B6-mt ALR compared to that of the CD-fed B6-mt BPL mice again with a different time course in both strains (main effect of the strains: descriptive p=0.0062, interaction between the strains and time:
descriptive p=0.0017, two-way non-parametric analysis of variance; Supplementary Fig. 4a ). Fig. 4g ). We did not observe any difference in energy expenditure, locomotor activity, or food intake levels other than water intake ( Supplementary Fig. 4 h-k) .
Discussion
In the present study, we presented experimental evidence that variations in mtDNA-encoded complex I genes, i.e., mt-Nd2 and mt-Nd5, differentially affected lifespan and metabolic phenotypes in mammals. Our results are in line with previously reported studies using
Drosophila carrying a mutation in the ND2 gene (ND2 del1 ), i.e., shorter lifespan as well as impaired fat storage, apart from Leigh syndrome-like (or spontaneous) neurological dysfunction 19, 30 . These studies suggested that ND2 mutations led to the shorter lifespan.
Mitochondrial functional studies using liver-mitochondria, cellular and tissue proteins did not exhibit major differences at the basal levels between the B6-mt ALR and B6-mtBPL mice.
However, once the cells received additional stimuli, i.e., immunological-(for lymphocytes) or metabolic stress (for hepatocytes), the levels of oxygen consumption, OXPHOS-linked ATP production and mitochondrial superoxide were significantly lower in the B6-mt ALR mice than those in the B6-mt BPL mice. This effect is likely caused by the lower levels of spare capacity and maximal respiration in the B6-mt ALR mice. In addition, glucose and lipid metabolism were skewed in this mouse strain. These alterations potentially resulted in a shorter lifespan and a higher susceptibility to diet-induced glucose intolerance in the B6-mt ALR mice. Interestingly the RNA-seq data pointed that the pathways involved in the mt-Nd2 mutant mice were mitochondrial pathways, e.g., OXPHOS pathways and metabolic pathways, as well as the ageing-related mammalian target of rapamycin (mTOR) pathway.
Another potential functional consequence of the mt-Nd2 variant in the B6-mt ALR mice was the altered levels of tryptophan, but not NAD + levels. Tryptophan is an essential amino acid that is metabolised by the kynurenine pathway through a series of metabolic reactions, and consequently NAD + is synthesised 31 . Tryptophan is only obtained through dietary intake, and no difference was observed in the levels of food intake between the strains in our indirect calorimetric cage data. This result suggests that the higher levels of tryptophan were due to the intrinsic metabolic alteration in the B6-mt ALR mice. A previous study demonstrates that tryptophan induces the phosphorylation of the mTOR, and accelerates non-alcoholic fatty liver disease in mice 32 , suggesting that the higher levels of tryptophan may contribute to shorten the lifespan in the B6-mt ALR mice by activating the mTOR pathway, which is in line with our RNA-seq data.
Interestingly, the m.4738C>A mutation, which is carried by the B6-mt ALR mice, causes the amino acid substitution of leucine to methionine at the 276 th peptide (Leu276Met). The 276 th peptide of human ND2 is also leucine, and this residue is known as the binding site for 1,2-dioleoyl-sn-glycero-3-phosphoethanolamine (https://www.ebi.ac.uk/pdbe/entry/pdb/5xtc/protein/17), suggesting that the mutation could potentially affect the binding capacity and/or affinity to glycerolipids, which are the components of the mitochondrial inner membrane. It is tempting to speculate that the mt-Nd2 mutation alters the structure of mitochondrial complex I, or super-complex, which may change its function, particularly under stress conditions, without influencing the protein levels of complex I subunits. A study to confirm the structural alteration by the mt-Nd2 mutation (m.4738C>A) will be performed in the future.
In humans, variants in the MT-ND2 gene, particularly m.5178C>A, exhibit a link with longevity 11 as well as lipid metabolism 14 and the incidence of age-related diseases, e.g.,
Parkinson's disease 33 . For this particular variant, the A allele is associated with extreme longevity and is protective for the abovementioned diseases, suggesting that lifespanassociated mtDNA variants are also responsible for age-related disease susceptibility. In the present study, we demonstrated that the B6-mt ALR mice, carrying the mt-Nd2 (m.4738C>A) variant, showed a significantly shorter lifespan and a higher susceptibility to diet-induced glucose intolerance than did the B6-mt BPL mice, which carry the wild-type C allele at m.4378
in mt-Nd2 and the mutant C allele at m.11902 in mt-Nd5. While the effect of each SNP appears to be variable in different species, it is clear that variations in the ND2 genes are strongly linked with ageing and age-associated diseases both in mice and humans. Mice had ad libitum access to filtered water and autoclaved pellet diet (Altromin, EasternWestphalia/Lippe, Germany). The animal facility was maintained at 21 °C on a 12 h light-12 h dark-cycle. Mice were allocated into two study groups: longitudinal study group to evaluate lifespan, and cross-sectional study group to evaluate the mice at different ages.
For the high fat diet feeding experiment, eight female mice of C57BL/6J-mt ALR/LtJ and C57BL/6J-mt BPL/1J at four weeks of age were fed a high fat diet (EF D12492 (I) 60 kJ% fat, Ssniff, Soest, Germany), while three age-and sex-matched mice of each strain were fed a control diet (EF D12450B mod. LS 13 kJ% fat, Ssniff) over eight weeks.
Animal use and all protocols used in this study were approved by local authorities of the Animal Care and Use Committee (V242-7224. 122-5, and 5-1/16, Kiel, Germany) and performed in accordance with the relevant guidelines and regulations by certified personnel. Female sexual maturity. Vaginal patency was evaluated as previously described 35 .
Plasma IGF-1 levels. Plasma IGF-1 levels were measured by a commercially available ELISA kit (Mouse/Rat IGF-1 Quantikine ELISA Kit, R&S Systems, Wiesbaden-Nordenstadt, Germany), according to the manufacturer's protocol.
Statistical analysis. Survival curves were estimated using the Kaplan-Meier method, and median lifespans with 95% confidence intervals were calculated. The differences of longevity between the strains were analysed using the log-rank method, as sensitivity analysis, Peto and Peto modification of the Gehan test. The R package survival in R version 3.5 was utilized for this 36 . Assuming that a most pronounced effect is visible in female mice and our previous studies demonstrating the impact of mtDNA variants on lifespan is more prominent in females 37 , the difference between strains in females was tested first. In a hierarchical way, difference between strains in males and in the sex-combined samples was tested for significance only in case that the previous test was significant at a significance level of 0.05.
Differences in glucose between strains and across time points were compared using a nonparametric analysis of variance for repeated in measures using the package nparLD in R, 
